• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病患者酶替代治疗前后的氧化应激、微量元素和循环微颗粒。

Oxidative stress, trace elements, and circulating microparticles in patients with Gaucher disease before and after enzyme replacement therapy.

机构信息

Department of Oncological Clinical Pathology, Flow Cytometry Lap, South Egypt Cancer Institute, Assiut University, Egypt.

Department of Pediatrics, Faculty of Medicine, Assiut University, Egypt

出版信息

Clin Appl Thromb Hemost. 2015 Jan;21(1):58-65. doi: 10.1177/1076029613489595. Epub 2013 May 22.

DOI:10.1177/1076029613489595
PMID:23698728
Abstract

UNLABELLED

We studied the level of lipid peroxide, nitric oxide (NO), trace elements (TEs), and microparticles (MPs) in Gaucher disease (GD) before and after 1 year of enzyme replacement therapy (ERT). A total of 15 children with GD and 15 healthy controls were enrolled in this study. Serum level of lipid peroxide, NO, and TEs was determined. The MPs were detected by flow cytometry. The level of lipid peroxide was significantly higher in the patients than in the controls even after ERT. Although NO level was normalized in the patients after ERT, zinc and copper were still lower in the patients after ERT. The percentages of various MPs were significantly higher in the patients than in the controls both before and after ERT. There were positive correlations between chitotriosidase and both lipid peroxide and total MPs.

CONCLUSION

The GD is associated with alteration in oxidant and antioxidant status and high level of circulating MPs.

摘要

未加标签

我们研究了戈谢氏病(GD)患者在酶替代治疗(ERT)前后脂质过氧化物、一氧化氮(NO)、微量元素(TEs)和微颗粒(MPs)的水平。本研究共纳入 15 名 GD 患儿和 15 名健康对照者。测定血清脂质过氧化物、NO 和 TEs 水平,用流式细胞术检测 MPs。ERT 后患者的脂质过氧化物水平仍显著高于对照组。尽管 ERT 后患者的 NO 水平正常化,但 ERT 后患者的锌和铜仍较低。ERT 前后患者各种 MPs 的百分比均显著高于对照组。几丁质酶与脂质过氧化物和总 MPs 均呈正相关。

结论

戈谢氏病与氧化应激和抗氧化状态改变以及循环 MPs 水平升高有关。

相似文献

1
Oxidative stress, trace elements, and circulating microparticles in patients with Gaucher disease before and after enzyme replacement therapy.戈谢病患者酶替代治疗前后的氧化应激、微量元素和循环微颗粒。
Clin Appl Thromb Hemost. 2015 Jan;21(1):58-65. doi: 10.1177/1076029613489595. Epub 2013 May 22.
2
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.在酶替代疗法时代,血浆壳三糖苷酶评估非神经病变型戈谢病严重程度及病情进展的价值。
J Inherit Metab Dis. 2014 Nov;37(6):991-1001. doi: 10.1007/s10545-014-9711-x. Epub 2014 May 16.
3
[Effect of enzyme replacement therapy on lipid profile in patients with Gaucher's disease].[酶替代疗法对戈谢病患者血脂谱的影响]
Med Clin (Barc). 2003 May 10;120(17):641-6. doi: 10.1016/s0025-7753(03)73797-x.
4
Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study.罗马尼亚 1 型戈谢病患者在酶替代治疗下的脂质谱动态变化:一项前瞻性研究。
J Inherit Metab Dis. 2013 May;36(3):555-63. doi: 10.1007/s10545-012-9529-3. Epub 2012 Sep 14.
5
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard.使用同位素标准品对1型戈谢病患者血浆和尿液中的葡萄糖基神经酰胺进行质谱定量分析。
Blood Cells Mol Dis. 2015 Apr;54(4):307-14. doi: 10.1016/j.bcmd.2015.01.006. Epub 2015 Jan 17.
6
Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.戈谢病患者停用替代酶(葡糖脑苷脂酶)治疗后血清壳三糖苷酶活性的变化
Clin Biochem. 2000 Mar;33(2):147-9. doi: 10.1016/s0009-9120(99)00098-3.
7
Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring.戈谢氏病患者的几丁质酶变体。对诊断和治疗监测的影响。
Clin Biochem. 2013 Dec;46(18):1804-7. doi: 10.1016/j.clinbiochem.2013.09.006. Epub 2013 Sep 20.
8
Biomarkers in Serbian patients with Gaucher disease.塞尔维亚戈谢病患者的生物标志物。
Clin Biochem. 2011 Aug;44(12):950-4. doi: 10.1016/j.clinbiochem.2011.05.016. Epub 2011 May 25.
9
The role of high density lipoprotein in Type 1 Gaucher disease.高密度脂蛋白在1型戈谢病中的作用。
Blood Cells Mol Dis. 2018 Feb;68:43-46. doi: 10.1016/j.bcmd.2016.11.005. Epub 2016 Nov 12.
10
Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment.1 型戈谢病中的铁蛋白血症:治疗下的机制和进展。
Blood Cells Mol Dis. 2012 Jun 15;49(1):53-7. doi: 10.1016/j.bcmd.2012.04.002. Epub 2012 May 3.

引用本文的文献

1
A kaleidoscopic view of extracellular vesicles in lysosomal storage disorders.溶酶体贮积症中细胞外囊泡的千变万化景象。
Extracell Vesicles Circ Nucl Acids. 2022 Dec 30;3(4):393-421. doi: 10.20517/evcna.2022.41. eCollection 2022.
2
Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease.戈谢氏病患者外周炎症和氧化应激生物标志物的生物学变异性。
Int J Mol Sci. 2022 Aug 16;23(16):9189. doi: 10.3390/ijms23169189.
3
Patients with Gaucher disease display systemic oxidative stress dependent on therapy status.
戈谢病患者表现出取决于治疗状态的全身性氧化应激。
Mol Genet Metab Rep. 2020 Dec 9;25:100667. doi: 10.1016/j.ymgmr.2020.100667. eCollection 2020 Dec.
4
Oxidative Stress and Trace Elements in Pulmonary Tuberculosis Patients During 6 Months Anti-tuberculosis Treatment.肺结核患者在 6 个月抗结核治疗期间的氧化应激与微量元素。
Biol Trace Elem Res. 2021 Apr;199(4):1259-1267. doi: 10.1007/s12011-020-02254-0. Epub 2020 Jun 25.
5
Gaucher Disease in Bone: From Pathophysiology to Practice.戈谢病骨骼表现:从病理生理学到临床实践
J Bone Miner Res. 2019 Jun;34(6):996-1013. doi: 10.1002/jbmr.3734. Epub 2019 Jun 24.
6
Oxidative stress parameters of Gaucher disease type I patients.Ⅰ型戈谢病患者的氧化应激参数
Mol Genet Metab Rep. 2015 May 22;4:1-5. doi: 10.1016/j.ymgmr.2015.05.001. eCollection 2015 Sep.